Biologics Contract Manufacturing
News and Events
MabPlex Lauded by Frost & Sullivan for Global Expansion of ADC Contract Manufacturing Services
Based on its recent analysis of the global antibody drug conjugate (ADC) contract manufacturing services market, Frost & Sullivan has recognized MabPlex International Ltd. (MabPlex) with the 2019 Global Growth Excellence Leadership Award. Download Frost & Sullivan’s 11 page report. Read the press release here.MabPlex Manufactured Monoclonal Antibody Receives IND Approval from the U.S. Food and Drug Administration
January 17, 2019
MabPlex International, Ltd, a global Contract Development and Manufacturing Organization (CDMO ) offering services in the development and manufacturing of...
Read MoreMabPlex M2 Commercial Manufacturing Facility Opening Ceremony
November 6, 2018
Jianmin Fang, PhD (Chairman of MabPlex International Ltd.) highlighted the development and growth of MabPlex over the past five years...
Read MoreMabPlex Announces Xinfang Li as Vice President of Process Development
January 9, 2018
January 09, 2018 07:00 AM Eastern Standard Time FREMONT, Calif. & YANTAI, SHANDONG, China--(BUSINESS WIRE)--MabPlex International, a world class CDMO...
Read More